NYSE:NRZ - New Residential Investment Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $11.50
Forecasted Upside: 7.88 %
Number of Analysts: 14
Breakdown:
0 Sell Ratings
1 Hold Ratings
13 Buy Ratings
0 Strong Buy Ratings

^$10.66 As of 06/24/2021 04:59 PM ET

▲ +0.13 (1.23%)

1 month | 3 months | 12 months

Get New New Residential Investment Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for NRZ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NRZ

^$11.50

▲ +7.88% Upside Potential

This price target is based on 14 analysts offering 12 month price targets for New Residential Investment in the last 3 months. The average price target is $11.50, with a high forecast of $13.00 and a low forecast of $10.00. The average price target represents a 7.88% upside from the last price of $10.66.

Current Consensus is Buy

The current consensus among 14 investment analysts is to buy stock in New Residential Investment. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
7 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

1/1/2020

0 strong buy ratings
6 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

3/31/2020

0 strong buy ratings
9 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

6/29/2020

0 strong buy ratings
9 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

9/27/2020

0 strong buy ratings
13 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

12/26/2020

0 strong buy ratings
13 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

3/26/2021

0 strong buy ratings
13 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

5/25/2021

0 strong buy ratings
13 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

6/24/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/20/2021	Raymond James	Boost Price Target	Outperform	$12.50 ➝ $13.00	Low
4/21/2021	Jonestrading	Reiterated Rating	Buy ➝ Hold		N/A
4/20/2021	Piper Sandler	Boost Price Target	Overweight	$11.50 ➝ $13.00	Medium
4/16/2021	BTIG Research	Boost Price Target	Buy	$12.00 ➝ $13.00	Medium
4/15/2021	Jonestrading	Downgrade	Buy ➝ Hold		Medium
3/25/2021	Royal Bank of Canada	Initiated Coverage	Outperform	$12.00	Medium
3/15/2021	Credit Suisse Group	Boost Price Target	Outperform	$11.00 ➝ $12.00	Low
2/16/2021	Piper Sandler	Boost Price Target		$10.00 ➝ $11.00	Low
2/10/2021	Raymond James	Boost Price Target	Outperform	$11.50 ➝ $12.50	Low
1/22/2021	JMP Securities	Boost Price Target	Market Outperform	$9.50 ➝ $10.00	Medium
12/18/2020	Keefe, Bruyette & Woods	Upgrade	Market Perform ➝ Outperform	$10.50	High
12/14/2020	Jefferies Financial Group	Initiated Coverage	Buy	$11.00	Low
11/24/2020	BTIG Research	Initiated Coverage	Buy		Low
11/24/2020	B. Riley	Boost Price Target	Buy	$9.50 ➝ $11.50	Medium
11/23/2020	Raymond James	Boost Price Target	Outperform	$10.50 ➝ $11.50	Low
11/6/2020	Wolfe Research	Initiated Coverage	Outperform		Medium
10/20/2020	Compass Point	Initiated Coverage	Buy	$11.00	High
10/19/2020	Credit Suisse Group	Boost Price Target	Outperform	$10.00 ➝ $11.00	Medium
9/24/2020	UBS Group	Initiated Coverage	Buy	$11.00	Medium
9/17/2020	Credit Suisse Group	Reiterated Rating	Buy		Low
9/8/2020	Credit Suisse Group	Reiterated Rating	Buy		Low
8/20/2020	Raymond James	Boost Price Target	Outperform	$8.50 ➝ $10.50	Medium
7/27/2020	Argus	Upgrade	Hold ➝ Buy	$10.00	Low
7/16/2020	Piper Sandler	Upgrade	Neutral ➝ Overweight	$8.50 ➝ $9.50	Medium
6/23/2020	B. Riley	Reiterated Rating	Buy	$9.00	High
6/12/2020	JMP Securities	Lower Price Target	Outperform	$17.00 ➝ $9.50	Low
5/28/2020	Credit Suisse Group	Reiterated Rating	Buy	$10.00	High
5/27/2020	Piper Sandler	Boost Price Target	Neutral	$7.00 ➝ $8.50	Low
4/2/2020	BTIG Research	Lower Price Target		$18.00 ➝ $10.50	High
4/2/2020	Argus	Downgrade	Buy ➝ Hold		High
2/13/2020	Nomura Securities	Boost Price Target	Buy	$18.50 ➝ $20.00	Low
1/13/2020	B. Riley	Reiterated Rating	Buy		Low
12/31/2019	Argus	Initiated Coverage	Buy	$18.00	Low
12/2/2019	Compass Point	Initiated Coverage	Buy	$19.00	Low
11/14/2019	Piper Jaffray Companies	Downgrade	Overweight ➝ Neutral	$16.00	High
10/25/2019	B. Riley	Set Price Target	Buy	$18.50	N/A
10/4/2019	Piper Jaffray Companies	Lower Price Target	Overweight	$18.00 ➝ $16.00	Low
9/6/2019	BTIG Research	Initiated Coverage	Buy	$18.00 ➝ $18.00	Medium
8/29/2019	B. Riley	Set Price Target	Buy	$19.00	Low
8/21/2019	B. Riley	Set Price Target	Buy	$19.00	High
8/19/2019	Wedbush	Reiterated Rating	Outperform		Low
3/27/2019	Nomura Securities	Initiated Coverage	Buy	$18.50	Low
1/4/2019	Credit Suisse Group	Reiterated Rating	Buy	$18.00	Low
10/5/2018	Raymond James	Initiated Coverage	Outperform ➝ Outperform	$20.00	Low
7/25/2018	Barclays	Boost Price Target	Overweight ➝ Overweight	$19.00 ➝ $21.00	Low
2/13/2018	B. Riley	Set Price Target	Buy	$19.00	Low
1/18/2018	Wedbush	Upgrade	Neutral ➝ Outperform	$20.00	Medium
11/29/2017	B. Riley	Reiterated Rating	Buy	$19.25	Low
11/1/2017	B. Riley	Reiterated Rating	Buy		N/A
10/30/2017	(FBRC)	Reiterated Rating	Buy	$19.25	N/A
10/24/2017	Barclays	Boost Price Target	Positive ➝ Overweight	$16.00 ➝ $19.00	N/A
10/9/2017	(FBRC)	Reiterated Rating	Buy	$17.50	N/A
9/14/2017	Keefe, Bruyette & Woods	Reiterated Rating	Buy	$18.00	Low
8/27/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$18.00	Low
8/3/2017	Keefe, Bruyette & Woods	Reiterated Rating	Buy	$18.00	Low
7/10/2017	(FBRC)	Reiterated Rating	Buy	$17.50	Low
6/20/2017	Wedbush	Downgrade	Outperform ➝ Neutral	$17.00 ➝ $16.50	High
6/6/2017	Keefe, Bruyette & Woods	Set Price Target	Buy	$17.00	Low
5/2/2017	(FBRC)	Reiterated Rating	Outperform	$17.50	Low
4/23/2017	(FBRC)	Reiterated Rating	Outperform	$17.50	Low
3/28/2017	(FBRC)	Reiterated Rating	Outperform	$17.50	Low
2/22/2017	(FBRC)	Boost Price Target	Outperform ➝ Outperform	$16.75 ➝ $17.50	N/A
2/6/2017	Keefe, Bruyette & Woods	Reiterated Rating	Outperform		N/A
1/31/2017	Compass Point	Upgrade	Neutral ➝ Buy		N/A
11/19/2016	Barclays	Set Price Target	Buy	$16.00	N/A
11/3/2016	(FBRC)	Reiterated Rating	Buy		N/A
11/3/2016	Nomura Securities	Reiterated Rating	Hold	$15.00	N/A
10/26/2016	Nomura Securities	Initiated Coverage	Neutral		N/A
10/5/2016	Wedbush	Initiated Coverage	Outperform	$17.00	N/A
9/11/2016	Credit Suisse Group	Reiterated Rating	Buy	$17.00	N/A
9/9/2016	Piper Jaffray Companies	Reiterated Rating	Overweight	$16.00	N/A
8/10/2016	Barclays	Boost Price Target	Overweight	$15.00 ➝ $16.00	N/A
8/8/2016	Credit Suisse Group	Set Price Target	Buy	$17.00	N/A

(Data available from 6/24/2016 forward)

New Residential Investment Corp., a real estate investment trust, focuses on investing in and managing residential mortgage related assets in the United States. It operates through five segments: Origination, Servicing, MSR Related Investments, Residential Securities and Loans, and Consumer Loans. The company invests in excess mortgage servicing rights (MSRs) on residential mortgage loans; and in servicer advances, including the basic fee component of the related MSRs. It also invests in real estate securities and residential mortgage loans, as well as in consumer loans, including unsecured and homeowner loans. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. New Residential Investment Corp. was founded in 2011 and is based in New York, New York.

Today's Range

Now: $10.66

$10.54

$10.66

50 Day Range

MA: $10.56

$9.89

$11.21

52 Week Range

Now: $10.66

$6.38

$11.48

Volume

99,359 shs

Average Volume

5,692,002 shs

Market Capitalization

$4.97 billion

P/E Ratio

10.88

Dividend Yield

7.51%

Beta

1.91

Frequently Asked Questions

What sell-side analysts currently cover shares of New Residential Investment?

The following Wall Street analysts have issued stock ratings on New Residential Investment in the last year: Argus, B. Riley, BTIG Research, Compass Point, Credit Suisse Group AG, Jefferies Financial Group Inc., JMP Securities, Jonestrading, Keefe, Bruyette & Woods, Piper Sandler, Raymond James, Royal Bank of Canada, UBS Group AG, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for NRZ.

What is the current price target for New Residential Investment?

12 Wall Street analysts have set twelve-month price targets for New Residential Investment in the last year. Their average twelve-month price target is $11.50, suggesting a possible upside of 8.6%. Raymond James has the highest price target set, predicting NRZ will reach $13.00 in the next twelve months. JMP Securities has the lowest price target set, forecasting a price of $10.00 for New Residential Investment in the next year.
View the latest price targets for NRZ.

What is the current consensus analyst rating for New Residential Investment?

New Residential Investment currently has 1 hold rating and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NRZ will outperform the market and that investors should add to their positions of New Residential Investment.
View the latest ratings for NRZ.

What other companies compete with New Residential Investment?

Other companies that are similar to New Residential Investment include Sun Communities, Mid-America Apartment Communities, Boston Properties, Healthpeak Properties, Duke Realty, VICI Properties, UDR, W. P. Carey, Equity LifeStyle Properties, Camden Property Trust, Annaly Capital Management, Iron Mountain, American Homes 4 Rent, Host Hotels & Resorts and Sino Land.

How do I contact New Residential Investment's investor relations team?

New Residential Investment's physical mailing address is 1345 AVENUE OF THE AMERICAS, NEW YORK NY, 10105. The real estate investment trust's listed phone number is 212-798-3150 and its investor relations email address is [email protected] The official website for New Residential Investment is www.newresi.com.